Matthew Rees

20PUBLICATIONS
77CO-AUTHORS
Gene and molecular therapyRadiation therapyPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Sep 22, 2026
Selinexor plus lenalidomide versus lenalidomide alone as maintenance therapy after autologous haematopoietic stem cell transplantation in newly diagnosed multiple myeloma: Results of the phase 3 ALLG MM23 (SeaLAND) trial.

|Apr 22, 2026
A multicenter study of progression risk and outcomes in solitary bone plasmacytoma with and without marrow involvement.

|Mar 30, 2026
Management of hematological toxicities after BCMA-directed CAR-T cell therapy.

Joselle Cook, Supriya Gupta, Nadine Abdallah

|Oct 16, 2025
EBV+ polymorphic B-cell lymphoproliferative disorder, NOS: a single-center study of a newly recognized pathologic entity.

Suheil Albert Atallah-Yunes, Thomas M Habermann, Matthew J Rees

|Sep 03, 2025
Multi-Institutional Study of ALK-Positive Large B-Cell Lymphoma: Outcomes in the Era of ALK Inhibitors and Biologically Informed Therapies.

Suheil Albert Atallah-Yunes, Chijioke C Nze, Rebecca L King

|Aug 14, 2025
The Evolving Treatment Landscape for the Elderly Multiple Myeloma Patient: From Quad Regimens to T-Cell Engagers and CAR-T.

Matthew James Rees, Hang Quach

Pageof 4

Frequent Collaborators

5 joint publications

Shaji Kumar

4 joint publications

Suheil Albert Atallah-Yunes

4 joint publications

Thomas M Habermann

4 joint publications

Yucai Wang